Last update 08 Oct 2025

BAY-3401016

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
BAY 3401016, BAY3401016
Target
SEMA3A
Action
antagonists
Mechanism
SEMA3A antagonists(semaphorin 3A antagonists)
Therapeutic Areas
Congenital DisordersSkin and Musculoskeletal DiseasesUrogenital Diseases+ [1]
Active Indication
Nephritis, Hereditary
Inactive Indication-
Originator Organization
Evotec SEEvotec SEBayer AGBayer AG
Active Organization
Bayer AGBayer AGEvotec SEEvotec SE
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with BAY-3401016
CTIS2022-502319-12-00
/ RecruitingPhase 1
- 21891
100 Clinical Results associated with BAY-3401016
Login to view more data
100 Translational Medicine associated with BAY-3401016
Login to view more data
100 Patents (Medical) associated with BAY-3401016
Login to view more data
100 Deals associated with BAY-3401016
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Nephritis, HereditaryPhase 2
United States
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
China
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
Japan
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
Argentina
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
Canada
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
Czechia
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
France
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
Germany
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
India
Bayer AGBayer AG
30 Sep 2025
Nephritis, HereditaryPhase 2
Italy
Bayer AGBayer AG
30 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free